MoneyWorks4Me

Amrutanjan Healthcare informs about board meeting

01 Nov 2017 Evaluate

Amrutanjan Healthcare has informed that a meeting of the Board of Directors is scheduled to be held on Thursday, November 9, 2017 at the registered office of the Company to consider and approve the Un-audited Financial Results along with the Limited Review Report for the quarter and half year ended September 30, 2017; and declaration of 1st interim dividend for the financial year 2017-18.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..